The company said Aetos Stemless addresses the growing demand for anatomical total shoulder replacement with a small operating room footprint, enabling an efficient procedure. Smith+Nephew designed it to maximize metaphyseal fixation and stability. It has an inlay collar, cruciate fins and porous titanium coating to encourage biological fixation.

Earlier this year, Smith+Nephew fully launched its Aetos shoulder system in the U.S. with additional FDA clearances. Aetos originally received FDA clearance in June 2023, bolstering the company’s upper extremity portfolio. London-based Smith+Nephew designed Aetos to restore patients’ range of motion and help minimize arthritic shoulder pain. The system features the Aetos Meta Stem designed for maximizing stability preserving bone and maintaining patient anatomy.